Sol-gel Technologies LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE: Sol-Gel Technologies Shareholder Update
Moshe Arkin and Arkin Dermatology Ltd. report increased beneficial ownership in Sol-Gel Technologies following a recent offering.
NASDAQ
SCHEDULE 13D/A: Moshe Arkin and M. Arkin Dermatology Significantly Increase Stake in Sol-Gel Technologies to Over 65%
Moshe Arkin and M. Arkin Dermatology Ltd. have significantly increased their beneficial ownership in Sol-Gel Technologies Ltd., now holding an aggregate of 65.31% of the outstanding Ordinary Shares through recent open market purchases.
NASDAQ
Moshe Arkin and M. Arkin Dermatology Ltd. have significantly increased their beneficial ownership in Sol-Gel Technologies Ltd., now controlling 61.79% of the company's outstanding Ordinary Shares.